Abstract
The effect of selective D 1 receptor agonists on acetylcholine (ACh) release in the striatum was investigated using in vivo microdialysis. Administration of the reactive enantiomer, (+)-SKF 38393 (2, 10 mg/kg s.c.), doses which elevate grooming and sniffing behaviour, increased ACh release by 40 and 75%, respectively. Another D 1 receptor agonist CY 204–283 (1 mg/kg s.c.) also produced a 75% increase in ACh output. The racemate (±)-SKF 38393 (20 mg/kg s.c.) increased ACh output by 60% and this was completely blocked by the D 1 receptor antagonist SCH 23390 (0.3 mg/kg s.c.). In contrast, administration of the D 2 receptor antagonist raclopride (1 mg/kg s.c.), 60 min after (±)-SKF 38393 (20 mg/kg s.c.), further increased ACh release. These results suggest that activation of D 1 receptors increases ACh release in vivo and that D 1 and D 2 receptors have opposing roles in the regulation of striatal ACh release.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.